Mesía R - Search Results

1

Twice-a-day radiotherapy for head and neck cancer: the Catalan Institute of Oncology experience.

Galiana R, Boladeras A, Mesía R, Gómez J, de Juan A, Mañós M, Nogués J, Navarro V, Guedea F. Galiana R, et al. Among authors: mesia r. Radiother Oncol. 2002 Jul;64(1):19-27. doi: 10.1016/s0167-8140(02)00141-x. Radiother Oncol. 2002. PMID: 12208570

2

Function preservation in stage III squamous laryngeal carcinoma: results with an induction chemotherapy protocol.

de Andrés L, Brunet J, López-Pousa A, Burgués J, Quer M, León X, Guedea F, Vega M, Mesía R, López JJ. de Andrés L, et al. Among authors: mesia r. Laryngoscope. 1995 Aug;105(8 Pt 1):822-6. doi: 10.1288/00005537-199508000-00010. Laryngoscope. 1995. PMID: 7630294 Clinical Trial.

3

Randomized trial of neoadjuvant cisplatin and fluorouracil versus carboplatin and fluorouracil in patients with stage IV-M0 head and neck cancer.

De Andrés L, Brunet J, López-Pousa A, Burgués J, Vega M, Tabernero JM, Mesía R, López JJ. De Andrés L, et al. Among authors: mesia r. J Clin Oncol. 1995 Jun;13(6):1493-500. doi: 10.1200/JCO.1995.13.6.1493. J Clin Oncol. 1995. PMID: 7751897 Clinical Trial.

4

Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.

Majem M, Mesia R, Mañós M, Gomez J, Galiana R, Cardenal F, Juan A, Montes A, Perez FJ, Nogues J, Llluch JR. Majem M, et al. Among authors: mesia r. Laryngoscope. 2006 Sep;116(9):1651-6. doi: 10.1097/01.mlg.0000231736.08477.47. Laryngoscope. 2006. PMID: 16954998

5

Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck.

Bernier J, Bonner J, Vermorken JB, Bensadoun RJ, Dummer R, Giralt J, Kornek G, Hartley A, Mesia R, Robert C, Segaert S, Ang KK. Bernier J, et al. Among authors: mesia r. Ann Oncol. 2008 Jan;19(1):142-9. doi: 10.1093/annonc/mdm400. Epub 2007 Sep 4. Ann Oncol. 2008. PMID: 17785763 Free article.

6

Treatment of patients with unresectable squamous head and neck cancer with induction chemotherapy followed by hyperfractionated radiotherapy.

Mesía R, Majem M, Barretina Ginesta MP, Galiana R, Mañós M, Guedea F, Montes A, Monner A, Pérez J, Cardenal F. Mesía R, et al. Cancer Radiother. 2008 Mar;12(2):88-95. doi: 10.1016/j.canrad.2007.09.148. Epub 2007 Dec 21. Cancer Radiother. 2008. PMID: 18155633

7

Hyperfractionated radiotherapy: improvement of survival in locally advanced nasopharyngeal carcinoma.

Mesia R, Maños M, Nogués J, Galiana R, Martínez García M, Lozano A, Tornero J, Ramón Germa J. Mesia R, et al. Ann Otol Rhinol Laryngol. 2009 Jun;118(6):442-8. doi: 10.1177/000348940911800607. Ann Otol Rhinol Laryngol. 2009. PMID: 19663376

8

Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck.

Mesía R, Rivera F, Kawecki A, Rottey S, Hitt R, Kienzer H, Cupissol D, De Raucourt D, Benasso M, Koralewski P, Delord JP, Bokemeyer C, Curran D, Gross A, Vermorken JB. Mesía R, et al. Ann Oncol. 2010 Oct;21(10):1967-1973. doi: 10.1093/annonc/mdq077. Epub 2010 Mar 24. Ann Oncol. 2010. PMID: 20335368 Free PMC article. Clinical Trial.

9

Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study.

Licitra L, Mesia R, Rivera F, Remenár É, Hitt R, Erfán J, Rottey S, Kawecki A, Zabolotnyy D, Benasso M, Störkel S, Senger S, Stroh C, Vermorken JB. Licitra L, et al. Among authors: mesia r. Ann Oncol. 2011 May;22(5):1078-1087. doi: 10.1093/annonc/mdq588. Epub 2010 Nov 3. Ann Oncol. 2011. PMID: 21048039 Free PMC article. Clinical Trial.

10

Phase I/II docetaxel plus concurrent hyperfractionated radiotherapy in locally advanced unresectable head and neck cancer (TAX.ES1.102 study).

Barnadas A, Mesía R, Majem M, Galiana R, López-Pousa A, de Vega JM, Margelí M, Valentí V, Anglada L, Lloansí A, Arellano A. Barnadas A, et al. Among authors: mesia r. Clin Transl Oncol. 2011 Apr;13(4):254-60. doi: 10.1007/s12094-011-0650-9. Clin Transl Oncol. 2011. PMID: 21493186 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

149 results

Search Page